 

UUI0109005515-1060-403E-ADBB-FA8640315595
TCGA-XM-ASRB-OlA—PR Redacted

|||||||ll|l||l||
illllllllllll

 

I
ll llllllllI|||I|||l|l|l||l|||l I
III II II I

SURGICAL PATHOLOGY REPORT

w Addendum *
Patient =
m s

  
 
   

Accession 8: *

Service:

Date of Procedure:
Date of Receipt:
Date of Report:

(Age : D

P
CO:

....

Clinical Diagnosis 5 History:

year old female with anterior mediastinel mess. Most likely stage I
tumor.

Specimens Submitted:
1: SP: Thymus (Es)
2: SP: Left interior pole or thymua

DIAGNOSIS: 7

f,» Tss , O
1. THYNUS} BXCISIONI
- THYMIC CARCINOMA WITH FOCAL PLEOMORPHISH (SEE NOTE) .

- THE ADJACENT THYHIC PARBNCHYMA SHOWS NULTILOCULAR CYSTIC CHANGE.
- NO TUMOR IS SEEN IN THE MARGINS 0P RESECTION. HOWEVER, THE TUMOR
EXTENDS TO WITHIN <1)!!! ‘

03' T33 INKED SURFACE.

NOTE:
4A! (963), CDS AND CD117 BUT NEGATIVE FOR C099. CD3 AND CD5 HIGBLIGB’I‘S THE
T-CELLS. THESE I'INDINGS SUPPORT THE DIAGNOSIS. KEV (BEER-15K) WILL BE
ORDERED AND THE RESULT WILL BE REFORTBD IN AN ADDENDUM.

THYMUS, LEFT INFERIOR POLE! EXCISION:
- BBNIGN THYMIC TISSUE WITH INVOLUTIONAL CHANGES.

Some of the inmunohistochmistz'y and 133 tests were developed and their
performance characteristics were determined by the

They have not been cleared or approved by the US food and Drug
Administration. The FDA has determined that such clearance or approval is
not necessary. These tests are used for clinical purposes. They should not

127D t 3
Wmmb NOS

JW 358623

5311‘ ¥ Jju/VWQZ'B‘Z?
egg) 5/52/24

”24 WWI/WW 5“.
'40P slid/La #1 ’Téé’i'v

IMMUNOEISTOCHEMICAL STAINING SHOWS THE MR 15 POSITVE POR A31:AE3,

be regarded as investigationel or to: research. This laboratory is certified
under the Clinical Laboratory Improvement Amendments of 1988 (CLIA ‘ 88) as

qualified to perform high complexity clinical laboratory testing.

I ATTKST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION 01“
THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE REVIEWED AND APPROVED
THIS REPORT.

"I Continued on next page ‘N

SURGICAL PAT on Y mason Accession #x -

Patient: Physician:

HRH: Service:

Account it: Date of Report:

“u ----- --~ ---------- ~~~---------------------— ------------- Page 2 at 3

"1' Report Electronically Signed out “1

Gross Descrintion:

1). The specimen is received fresh for intraoperstive consultation, labeled
”thymus,“ and consists of thymus (12 x 9 x 1.5 cm), oriented with a black
stitch indicating the right supexior pole. The tissue contains s
we11~circumscribed. white—ten mess (4.0 x 4.0 x 2.5 cm) with a slightly
lobuleted cut surface, located in the inferior right aspect o! the specimen.
The mass shows a rounded border with tocel infiltration of adipose tissue.
The remaining thymic tissue is normal in appearance. The resection margins
are inked black. Representative sections submitted.

Summary of sections:

PSC— frozen section control
T- tumor

TH- non-neoplastic thymus

2). The specimen is received in formalin, labeled "Left inferior pole of
thymus" and consists of e 1.5 x 1.5 x 0.5 cm oval fragment of lobuleted
adipose tissue. Entirely inked black, bisected and entirely submitted.

Summary 01! sections:
U - undesigneted

Sumary of Sections:
Part 1: SP: Thymus (Es)

Block Sect . Site PCs

1 fee 1
10 t 10
2 th 2

Part 2: SP: Left inferior pole of thymus

Block sect. Site PCs

1 U 2

Procedures [Addenda x

Addendum

Date ordered: status: Signed Out

M Continued on next page "I

SURGICAL PATHOLOGY :r Accession 1t 1“

Patient: Physician:

HEN: Service:

Account 4}: Date of Report:

------------- -------—---------------—----------------------- Page 3 of 3
Date Complete: By:

Date Reported 2

Addendum Diagnosis

IMMUNOHISTOCHEMISTRY SHOWS THE TUMOR IS NEGATIVE FOR KEV (BEER-168) . THE
MORPHOLOGY OF THE TUMOR IS CONSISTENT WITH A THYMIC CARCINOMA WITH
hWHOZPImLIOﬂA—LIKR CARCINOMA FEATURES. THIS CASE WAS SHOWN IN

CONSULTATION TO OR. (HEAD AND NECK PATHOLOGY SERVICE) WHO
CONCURS WITH THE DIAGNOSIS.

Some or the immunohistochemistry and 153 tests were developed and their
pertormance characteristics were determined by the

They have not been cleared or approved by the US Food and Drug
Administration. The FDA has determined that such clearance or approval is
not necessary. These tests are used for clinical purposes. They should not
be regarded as investigations]. or tor research. This laboratory is certified
under the clinical Laboratory Improvement Amendments of 1983 (CLIA ' 88) as
qualified to perform high complexity clinical laboratory testing.

Intraoperative Consultation:
Note: The diagnoses given in this section pertain only to the tissue sample
examined at the time of the intraoperative consultation.

1. FROZEN SECTION DIAGNOSIS: 8P: THYMUS (F8) : MALIGNAN‘I’ BPITHELIAL
NBOPLASM, FAVOR CARCINOMA.

PERMANENT DIAGNOSIS : SAME

Note: The diagnoses given in this section pertain only to the tissue sample
examined at the time of the intraoperative consultation.

1. FROZEN SECTION DIAGNOSIS: SP: W3 (PS) : MALIGNANT EPITHKLIAL
HEOPLASMA FAVOR CARCINOMA.

PERMANENT DIAGNOSIS z SAME

** End. of Report **

 

 

 

 

 

 

TCGA Pathologic Diagnosis Discrepancy Form

V4.00

 

 

 

 

 

 

Insggcgions: The TCGA Pathologic Diagnosis Discrepancy Form should be completed when the pathologic diagnosis
documented on the initial pathology report for a case submitted
Case Quality Control Form completed for the submitted case.

for TCGA is inconsistent with the diagnosis provided on the

 

 

 

 

 

 

 

 

Tissue Source Site (T38): T33 Identifier: TSS Unique Patient Identiﬁer:

Completed By (Interviewer Name on OpenClinica}: Completed Date:

{Diagnosis Information 1
# Data Element Entry Alternatives Working Instructions

 

Pathologic Diagnosis

Thymlc Carcinoma with

Provide the diagnosis/ histologic subtype(s) documented on
the initial pathology report for this case. if the histology for

 

 

 

for TCGA, as reﬂected
on the CQCF.

 

1 Provided on initial ' this case is mixed, provide all listed subtypes
Pathology Report focal pieomorphlsm
. . Provide the histologic features selected on the TCGA Case
l-hstolo it features of . .
the samgple provided Thy m o m a ~Thymic Carcinoma (Type C) Quality Control Pom completed for this case.
2 ~-—-—-——.—_——_—___

 

 

 

Discrepancy between Pathology Report and Case Quality Control Form

7

 

3

Provide the reason for
the discrepancy
between the pathology
report and the TCGA
Case Quality Control
Form.

There is no pleomorphism in the top slide. The tumor
original diagnosis indicates focal pleomorphism. This

has no bearing in the diagnosis or tumor classification.

Provide a reason describing why the diagnosis on the initial
pathology report for this case is not consistent with the
diagnosis selected on the TCGA Case Quality Control Form.

 

 

 

Name ofTSS Reviewing
Pathologist or
Biorepository Director

 

Dr.

 

 

Provide the name of the pathologist who reviewed this case
for TCGA.

 

 

I acknowledge that the above information provided by my institution is true and correct and has been quality controlled.

 

TSS Reviewing Pathologist or Biorepository Director

Date

I acknowledge that the above information provided by my institution is true and correct and has been quality controlled. The Attending Pathologist or the
Department Chairman has been informed or is aware of the above discrepancy in diagnoses.

 

Principal lnvoétigator Signature

 

Date

